United States Stem Cells Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Stem Cells Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Stem Cells Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Stem Cells Overall Market Size
2.1 United States Stem Cells Market Size: 2021 VS 2027
2.2 United States Stem Cells Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cells Players in United States Market
3.2 Top United States Stem Cells Companies Ranked by Revenue
3.3 United States Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Stem Cells Companies in United States Market, by Revenue in 2020
3.5 Companies Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cells Players in United States Market
3.6.1 List of Tier 1 Stem Cells Companies in United States
3.6.2 List of Tier 2 and Tier 3 Stem Cells Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Stem Cells Market Size Markets, 2021 & 2027
4.1.2 Stem Cell Storage
4.1.3 Stem Cell Pharmaceutical and Treatment
4.2 By Type - United States Stem Cells Revenue & Forecasts
4.2.1 By Type - United States Stem Cells Revenue, 2016-2021
4.2.2 By Type - United States Stem Cells Revenue, 2022-2027
4.2.3 By Type - United States Stem Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Stem Cells Market Size, 2021 & 2027
5.1.2 Diseases of the Central Nervous System
5.1.3 Cardiovascular Disease
5.1.4 Diabetes
5.1.5 Cancer
5.1.6 Genetic Diseases
5.1.7 Autoimmune Disease
5.1.8 Bone and Cartilage Repair
5.1.9 Other
5.2 By Application - United States Stem Cells Revenue & Forecasts
5.2.1 By Application - United States Stem Cells Revenue, 2016-2021
5.2.2 By Application - United States Stem Cells Revenue, 2022-2027
5.2.3 By Application - United States Stem Cells Revenue Market Share, 2016-2027
6 Stem Cells Companies Profiles
6.1 Osiris Therapeutics
6.1.1 Osiris Therapeutics Company Details
6.1.2 Osiris Therapeutics Business Overview
6.1.3 Osiris Therapeutics Stem Cells Introduction
6.1.4 Osiris Therapeutics Stem Cells Revenue in United States Market (2016-2021)
6.1.5 Osiris Therapeutics Recent Developments
6.2 NuVasive
6.2.1 NuVasive Company Details
6.2.2 NuVasive Business Overview
6.2.3 NuVasive Stem Cells Introduction
6.2.4 NuVasive Stem Cells Revenue in United States Market (2016-2021)
6.2.5 NuVasive Recent Developments
6.3 Chiesi Pharmaceuticals
6.3.1 Chiesi Pharmaceuticals Company Details
6.3.2 Chiesi Pharmaceuticals Business Overview
6.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
6.3.4 Chiesi Pharmaceuticals Stem Cells Revenue in United States Market (2016-2021)
6.3.5 Chiesi Pharmaceuticals Recent Developments
6.4 Medi-post
6.4.1 Medi-post Company Details
6.4.2 Medi-post Business Overview
6.4.3 Medi-post Stem Cells Introduction
6.4.4 Medi-post Stem Cells Revenue in United States Market (2016-2021)
6.4.5 Medi-post Recent Developments
6.5 JCR Pharmaceutical
6.5.1 JCR Pharmaceutical Company Details
6.5.2 JCR Pharmaceutical Business Overview
6.5.3 JCR Pharmaceutical Stem Cells Introduction
6.5.4 JCR Pharmaceutical Stem Cells Revenue in United States Market (2016-2021)
6.5.5 JCR Pharmaceutical Recent Developments
6.6 MolMed
6.6.1 MolMed Company Details
6.6.2 MolMed Business Overview
6.6.3 MolMed Stem Cells Introduction
6.6.4 MolMed Stem Cells Revenue in United States Market (2016-2021)
6.6.5 MolMed Recent Developments
6.7 Pharmicell
6.7.1 Pharmicell Company Details
6.7.2 Pharmicell Business Overview
6.7.3 Pharmicell Stem Cells Introduction
6.7.4 Pharmicell Stem Cells Revenue in United States Market (2016-2021)
6.7.5 Pharmicell Recent Developments
6.8 Anterogen
6.8.1 Anterogen Company Details
6.8.2 Anterogen Business Overview
6.8.3 Anterogen Stem Cells Introduction
6.8.4 Anterogen Stem Cells Revenue in United States Market (2016-2021)
6.8.5 Anterogen Recent Developments
6.9 Takeda (TiGenix)
6.9.1 Takeda (TiGenix) Company Details
6.9.2 Takeda (TiGenix) Business Overview
6.9.3 Takeda (TiGenix) Stem Cells Introduction
6.9.4 Takeda (TiGenix) Stem Cells Revenue in United States Market (2016-2021)
6.9.5 Takeda (TiGenix) Recent Developments
6.10 CBR
6.10.1 CBR Company Details
6.10.2 CBR Business Overview
6.10.3 CBR Stem Cells Introduction
6.10.4 CBR Stem Cells Revenue in United States Market (2016-2021)
6.10.5 CBR Recent Developments
6.11 ViaCord
6.11.1 ViaCord Company Details
6.11.2 ViaCord Business Overview
6.11.3 ViaCord Stem Cells Introduction
6.11.4 ViaCord Stem Cells Revenue in United States Market (2016-2021)
6.11.5 ViaCord Recent Developments
6.12 Esperite
6.12.1 Esperite Company Details
6.12.2 Esperite Business Overview
6.12.3 Esperite Stem Cells Introduction
6.12.4 Esperite Stem Cells Revenue in United States Market (2016-2021)
6.12.5 Esperite Recent Developments
6.13 LifeCell
6.13.1 LifeCell Company Details
6.13.2 LifeCell Business Overview
6.13.3 LifeCell Stem Cells Introduction
6.13.4 LifeCell Stem Cells Revenue in United States Market (2016-2021)
6.13.5 LifeCell Recent Developments
6.14 CCBC
6.14.1 CCBC Company Details
6.14.2 CCBC Business Overview
6.14.3 CCBC Stem Cells Introduction
6.14.4 CCBC Stem Cells Revenue in United States Market (2016-2021)
6.14.5 CCBC Recent Developments
6.15 VCANBIO
6.15.1 VCANBIO Company Details
6.15.2 VCANBIO Business Overview
6.15.3 VCANBIO Stem Cells Introduction
6.15.4 VCANBIO Stem Cells Revenue in United States Market (2016-2021)
6.15.5 VCANBIO Recent Developments
6.16 BOYA LIFE
6.16.1 BOYA LIFE Company Details
6.16.2 BOYA LIFE Business Overview
6.16.3 BOYA LIFE Stem Cells Introduction
6.16.4 BOYA LIFE Stem Cells Revenue in United States Market (2016-2021)
6.16.5 BOYA LIFE Recent Developments
6.17 Beike Biotechnology
6.17.1 Beike Biotechnology Company Details
6.17.2 Beike Biotechnology Business Overview
6.17.3 Beike Biotechnology Stem Cells Introduction
6.17.4 Beike Biotechnology Stem Cells Revenue in United States Market (2016-2021)
6.17.5 Beike Biotechnology Recent Developments
6.18 International Medical
6.18.1 International Medical Company Details
6.18.2 International Medical Business Overview
6.18.3 International Medical Stem Cells Introduction
6.18.4 International Medical Stem Cells Revenue in United States Market (2016-2021)
6.18.5 International Medical Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Stem Cells Market Opportunities & Trends in United States Market
Table 2. Stem Cells Market Drivers in United States Market
Table 3. Stem Cells Market Restraints in United States Market
Table 4. Key Players of Stem Cells in United States Market
Table 5. Top Stem Cells Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Stem Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Stem Cells Revenue Share by Companies, 2016-2021
Table 8. Companies Stem Cells Product Type
Table 9. List of Tier 1 Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Stem Cells Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Stem Cells Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Stem Cells Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Stem Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Stem Cells Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Stem Cells Revenue (US$, Mn), 2022-2027
Table 17. Osiris Therapeutics Company Details
Table 18. Osiris Therapeutics Business Overview
Table 19. Osiris Therapeutics Stem Cells Product
Table 20. Osiris Therapeutics Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Osiris Therapeutics Recent Developments
Table 22. NuVasive Company Details
Table 23. NuVasive Business Overview
Table 24. NuVasive Stem Cells Product
Table 25. NuVasive Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. NuVasive Recent Developments
Table 27. Chiesi Pharmaceuticals Company Details
Table 28. Chiesi Pharmaceuticals Business Overview
Table 29. Chiesi Pharmaceuticals Stem Cells Product
Table 30. Chiesi Pharmaceuticals Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Chiesi Pharmaceuticals Recent Developments
Table 32. Medi-post Company Details
Table 33. Medi-post Business Overview
Table 34. Medi-post Stem Cells Product
Table 35. Medi-post Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Medi-post Recent Developments
Table 37. JCR Pharmaceutical Company Details
Table 38. JCR Pharmaceutical Business Overview
Table 39. JCR Pharmaceutical Stem Cells Product
Table 40. JCR Pharmaceutical Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. JCR Pharmaceutical Recent Developments
Table 42. MolMed Company Details
Table 43. MolMed Business Overview
Table 44. MolMed Stem Cells Product
Table 45. MolMed Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. MolMed Recent Developments
Table 47. Pharmicell Company Details
Table 48. Pharmicell Business Overview
Table 49. Pharmicell Stem Cells Product
Table 50. Pharmicell Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Pharmicell Recent Developments
Table 52. Anterogen Company Details
Table 53. Anterogen Business Overview
Table 54. Anterogen Stem Cells Product
Table 55. Anterogen Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Anterogen Recent Developments
Table 57. Takeda (TiGenix) Company Details
Table 58. Takeda (TiGenix) Business Overview
Table 59. Takeda (TiGenix) Stem Cells Product
Table 60. Takeda (TiGenix) Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Takeda (TiGenix) Recent Developments
Table 62. CBR Company Details
Table 63. CBR Business Overview
Table 64. CBR Stem Cells Product
Table 65. CBR Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. CBR Recent Developments
Table 67. ViaCord Company Details
Table 68. ViaCord Business Overview
Table 69. ViaCord Stem Cells Product
Table 70. ViaCord Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. ViaCord Recent Developments
Table 72. Esperite Company Details
Table 73. Esperite Business Overview
Table 74. Esperite Stem Cells Product
Table 75. Esperite Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Esperite Recent Developments
Table 77. LifeCell Company Details
Table 78. LifeCell Business Overview
Table 79. LifeCell Stem Cells Product
Table 80. LifeCell Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. LifeCell Recent Developments
Table 82. CCBC Company Details
Table 83. CCBC Business Overview
Table 84. CCBC Stem Cells Product
Table 85. CCBC Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. CCBC Recent Developments
Table 87. VCANBIO Business Overview
Table 88. VCANBIO Company Details
Table 89. VCANBIO Stem Cells Product
Table 90. VCANBIO Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. VCANBIO Recent Developments
Table 92. BOYA LIFE Company Details
Table 93. BOYA LIFE Business Overview
Table 94. BOYA LIFE Stem Cells Product
Table 95. BOYA LIFE Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. BOYA LIFE Recent Developments
Table 97. Beike Biotechnology Company Details
Table 98. Beike Biotechnology Business Overview
Table 99. Beike Biotechnology Stem Cells Product
Table 100. Beike Biotechnology Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. Beike Biotechnology Recent Developments
Table 102. International Medical Company Details
Table 103. International Medical Business Overview
Table 104. International Medical Stem Cells Product
Table 105. International Medical Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. International Medical Recent Developments
List of FiguresFigure 1. Stem Cells Segment by Type
Figure 2. Stem Cells Segment by Application
Figure 3. United States Stem Cells Market Overview: 2020
Figure 4. United States Stem Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Stem Cells Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Stem Cells Revenue in 2020
Figure 7. By Type - United States Stem Cells Revenue Market Share, 2016-2027
Figure 8. By Application - United States Stem Cells Revenue Market Share, 2016-2027
Figure 9. Osiris Therapeutics Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. NuVasive Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Chiesi Pharmaceuticals Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Medi-post Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. JCR Pharmaceutical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. MolMed Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Pharmicell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Anterogen Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Takeda (TiGenix) Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. CBR Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. ViaCord Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Esperite Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. LifeCell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. CCBC Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. VCANBIO Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. BOYA LIFE Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Beike Biotechnology Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. International Medical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)